je mehr ich mich mit den Produkten der Firma beschäftige um so mehr gefallen die mir!
Klingt für mich jedenfalls sehr interessant...
news: DNAPrint Secures a Distributor for its DNA Witness(TM) Test to Better Serve Law Enforcement
2/17/2004 11:50:00 AM
SARASOTA, Fla., Feb 17, 2004 /PRNewswire-FirstCall via COMTEX/ -- DNAPrint genomics, Inc. (DNAPrint or the "Company") has teamed up with Lynn Peavey Company of Kansas City to advance the use of DNA Witness(TM) in the law enforcement community. Lynn Peavey is the leader in providing law enforcement with forensic innovations for use at the crime scene and in the laboratory. Lynn Peavey reaches over 17,000 law enforcement agencies across the country. DNA Witness(TM) is an advanced presumptive DNA test that determines the Biogeographical Ancestry of an individual with no other information but the person's genetic code.
"This is a great opportunity to give our customer base another shot at solving the mystery of committed crimes...because, often they have no idea of which direction to go in an investigation once the leads have not produced a suspect," said Doug Peavey, President of Lynn Peavey Company.
"This partnership will increase our presence in the law enforcement community," said Zach Gaskin, Technical Director of Forensics with DNAPrint. "This is the opportunity that we needed to get the DNA Witness test into the hands of the people who need it most. There are over 70,000 unsolved cases in the National DNA Index System, and many of them could benefit from this testing. We are excited about the distributorship because the Lynn Peavey Company is a well-respected supplier in the law enforcement community and already does business with most of the agencies in the U.S."
"DNAWitness, our flagship product for the detective is a presumptive test, and Doug Peavey's company is well positioned to offer this test to the crime lab and detective community," said Richard Gabriel, CEO and President. "We continue to invest in our technology for the forensics market because the crime numbers are staggering. Our laboratory can process thousands of samples per day but getting the law enforcement community to use our product requires the help and support of Lynn Peavey Company. Doug's company sends catalogs all over the world, and we are prepared to help detectives solve crimes no matter where they occur. In the state of Florida, there were over 26,000 aggravated sexual assaults, extrapolate that over all the states, then Europe, then South America ... these are staggering statistics." He concluded, "We are teaming up with Lynn Peavey Company and offering training seminars on how, where, why, when to use DNAWitness. The kit itself is free but if you don't know how to use it and when and why and what it tells you, then it doesn't mean much to a detective. Our goal is to have detectives, medical examiners and crime labs use our service to help them catch criminals, identify unknown remains and solve cold cases. We are another tool in their kit."
"DNAWitness has been a powerful instrument in testing crime scene DNA left by the donor," said Tony Frudakis, Chief Scientific Officer and Founder of DNAPrint genomics, Inc. "We continue to add features to the product and we expect that soon, detectives will have another new feature, eye color; then later on skin shade, maybe height and other descriptors. We want every criminal to know that when they commit a crime, they left behind a fuzzy photo, a blurry driver's license with no name on it. Detectives are really good at working with seemingly disconnected and sparse evidence, and adding the name to the fuzzy photo is in their realm of expertise. This presumptive test can be used on all crimes, not just the murders but the sexual assaults, burglaries, car thefts, robberies, and many other pieces of evidence. Law enforcement officers across the world know that crimes such as these can and often do lead to the more violent crimes, murder being the worst."
DNAPrint genomics, Inc. and Lynn Peavey Company are attending the 56th Annual American Academy of Forensic Science Meeting in Dallas on February 16- 21, 2004 where Zach Gaskin is presenting on the use of DNA Witness in the Louisiana Serial Killer Case. Their tradeshow booth numbers are 517 for DNAPrint and 416-417 for Lynn Peavey Company.
About DNAPrint genomics, Inc.
DNAPrint(TM) genomics, Inc., ("DNAPrint (TM)" or the "Company"), is a genomics science company focused on the sale of proprietary genetic testing products and services. The Company's core technologies for efficiently targeting single nucleotide polymorphisms ("SNPs") enable it to provide predictive genetic tests at a significant cost advantage over its competitors.
The Company has identified and patented the maps of certain SNPs with wide commercial applications called Ancestry Informative Markers ("AIMS"). The Company believes that AIMs are the key for unlocking the relationship between common variants and common anthropometric, disease and drug response traits. Effectively mapping disease and drug response sequences could lead to the development of clinical classifiers for improving drug development, personalizing drug use and empowering forensics investigations. The Company's patented AIMs are integral to the Company's strategy of offering DNA tests that provide valuable predictive results, including a person's physical characteristics, Biogeographical Ancestry ("BGA"), and predisposition to respond to certain pharmaceutical drugs. The Company's tests target four distinct markets -- forensics, consumer, pharmacogenomics (predicting drug response) and outsourced screening services. The Company is traded on the Nasdaq OTC Bulletin Board under the ticker symbol: DNAP. For more information about the company, please visit www.dnaprint.com.
All statements in this press release that are not historical are forward- looking statements within the meaning of Section 21E of the Securities Exchange Act as amended. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, uncertainties relating to technologies, product development, manufacturing, market acceptance, cost and pricing of DNAPrint's products, dependence on collaborations and partners, regulatory approvals, competition, intellectual property of others, and patent protection and litigation. DNAPrint genomics, Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in DNAPrint's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based.
Media and Press Contacts
Richard Gabriel
CEO/President
DNAPrint Genomics, Inc.
941-366-3400
SOURCE DNAPrint Genomics, Inc.
Richard Gabriel, CEO and President, DNAPrint Genomics, Inc.,
+1-941-366-3400
www.dnaprint.com
